摘要
Over the past decade, many new cancer treatments have been developed and made available to patients. However, in most cases, these treatments only benefit a specific subgroup of patients, making the selection of treatment for a specific patient an essential but challenging task for oncologists.Although some biomarkers were found to associate with treatment response, manual assessment is time-consuming and subjective. With the rapid developments and expanded implementation of artificial intelli-gence (AI) in digital pathology, many biomarkers can be quantified automatically from histopathology images. This approach allows for a more efficient and objective assessment of biomarkers, aiding oncologists in formulating personalized treatment plans for cancer patients.This review presents an overview and summary of the recent studies on biomarker quantification and treat-ment response prediction using hematoxylin-eosin (H&E) stained pathology images. These studies have shown that an AI-based digital pathology approach can be practical and will become increasingly important in improving the selection of cancer treatments for patients.
学科与关键词
- AI in Computational Pathology of Cancer: Improving DiagnosticWorkflows and Clinical Outcomes?Cifci, Didem; Veldhuizen, Gregory P.; Foersch, Sebastian; Kather, Jakob Nikolas*ANNUAL REVIEW OF CANCER BIOLOGY, 2023, 7: 57-71.被引 11
- Deep Learning-Based Prediction of Molecular Tumor Biomarkers from H&E: A Practical ReviewCouture, Heather D.*Journal of Personalized Medicine, 2022, 12(12): 2022.被引 13
- Computational pathology to improve biomarker testing in breast cancer: how close are we?Sajjadi, Elham; Frascarelli, Chiara; Venetis, Konstantinos; Bonizzi, Giuseppina; Ivanova, Mariia; Vago, Gianluca; Guerini-Rocco, Elena; Fusco, Nicola*EUROPEAN JOURNAL OF CANCER PREVENTION, 2023, 32(5): 460-467.被引 8
